Skip to content
itopride
EntityQ4409774· pop 10· linked from 707 articles

Also known as N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide

Itopride (INN; brand name Ganaton) is a prokinetic benzamide derivative. These drugs inhibit dopamine and acetylcholine esterase enzyme and have a gastrokinetic effect. Itopride is indicated for the treatment of functional dyspepsia and other gastrointestinal conditions. It is a combined D2 receptor antagonist and acetylcholinesterase inhibitor. Itopride is the dimethoxy analog of trimethobenzamide.

Key facts

Drug.KEGG
D08094
Drug.KEGG2
D02729
Drug.Verifiedfields
changed
Drug.verifiedrevid
444538072
Drug.image
Itopride.svg
Drug.image_class
skin-invert-image
Drug.width
260
Drug.image2
3D Itopride.png
Drug.image_class2
bg-transparent
Drug.tradename
Ganaton
Drug.legal_status
Rx-only
Drug.routes_of_administration
By mouth
Drug.ATC_prefix
A03
Drug.ATC_suffix
FA07
Drug.bioavailability
~60% (Tmax = 35±5 min)
Drug.protein_bound
96%
Drug.metabolism
Extensive hepatic (FMO1 and FMO3), primarily N-oxidation
Drug.elimination_half life
5.7±0.3 hours

via Wikipedia infobox

Wikidata facts

Mass
358.189257
Show 3 more facts
chemical formula
C₂₀H₂₆N₂O₄
canonical SMILES
CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC
Commons category
Itopride
Sources (2)

via Wikidata · CC0

~6 min read

Article

10 sections
Contents
  • Medical uses
  • Adverse drug reactions
  • Cardiac studies
  • Pharmacology
  • Pharmacokinetics
  • Mechanism of action
  • Society and culture
  • Names
  • References
  • External links

Itopride (INN; brand name Ganaton) is a prokinetic benzamide derivative. These drugs inhibit dopamine and acetylcholine esterase enzyme and have a gastrokinetic effect. Itopride is indicated for the treatment of functional dyspepsia and other gastrointestinal conditions. It is a combined D2 receptor antagonist and acetylcholinesterase inhibitor. Itopride is the dimethoxy analog of trimethobenzamide.

==Medical uses== thumb|240px|A blister package of Ganaton (Itopride) 50 mg tablets intended for distribution in the Slovak Republic. Typically, itopride is indicated in the treatment of GI symptoms caused by reduced GI motility: dyspepsia of a non-ulcer/dysmotility type (gastric "fullness", discomfort, and possible pain) gastroparesis (delayed gastric emptying) anorexia heartburn regurgitation bloating nausea and vomiting other possible gastric, prolactin, or dopamine related conditions

Gallery (2)

Connections

Categories